Two independent high-throughput zebrafish behavioral screens of tens of thousands of compounds identify the 'finazines', a novel group of antipsychotics, and their endogenous genetic target, the σ1 receptor.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Thrombopoietic stimulating activity of rhTyrRS (Y341A)
Scientific Reports Open Access 22 September 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Hyman, S.E. Sci. Transl. Med. 4, 155cm11 (2012).
Bruni, G. et al. Nat. Chem. Biol. 12, 559–566 (2016).
Rennekamp, A.J. et al. Nat. Chem. Biol. 12, 552–558 (2016).
Kalueff, A.V. et al. Zebrafish 10, 70–86 (2013).
Martineau, P.R. & Mourrain, P. Methods 62, 292–303 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Leung, L., Mourrain, P. Zebrafish uncover novel antipsychotics. Nat Chem Biol 12, 468–469 (2016). https://doi.org/10.1038/nchembio.2114
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2114
This article is cited by
-
Thrombopoietic stimulating activity of rhTyrRS (Y341A)
Scientific Reports (2017)